We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.50 | 1.40 | 1.60 | 1.50 | 1.50 | 1.50 | 195,426 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -4.29 | 2.03M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/8/2020 09:15 | When is it dated stig | albert3591 | |
16/8/2020 08:23 | Very positive news. Thanks for sharing Stig. | hodhasharon | |
16/8/2020 06:46 | WOW. Check the date peoplle. | albert3591 | |
15/8/2020 23:41 | WOW ! VAL201 Clinical Trial results soon. If they can get that licenced Physiomics entitled to 'revenue sharing' !!! 13 September 2011 Physiomics Plc (“Physiomics Collaborative Agreement “ValiRx to use Physiomics’ Virtual Tumour technology to accelerate development of promising prostate cancer drug” Physiomics Plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a collaborative agreement (“Agreement Physiomics will use its systems biology expertise and ‘Virtual Tumour’ proprietary technology to assist ValiRx to accelerate the development of its lead therapeutic, VAL201, and speed its progress through the next stage of VAL201’s preclinical programme to support the regulatory requirements prior to its entering clinical trials. The Agreement is on a revenue sharing basis, so that Physiomics will not receive a fee for their work but will receive a percentage of any licensing income received by ValiRx for the compound for use in treating prostate cancer, in due course. The programme will create new IP, which will add value for both parties, with ValiPharma retaining both ownership of all VAL201 associated new IP resulting from the programme and retaining all rights for the commercialisation of VAL201. | the stigologist | |
15/8/2020 19:04 | Do not join closed chat groups for shares. Rampers Paradise. | davevt | |
15/8/2020 15:47 | I have issues with VAL previous Management and history but they are under new management and have £2m cash to spend on R&D VAL Telegram group | the stigologist | |
14/8/2020 15:22 | Retrospective predictions eh davevt? You really know your onions mate. Checkout my NetFix MicroSoft and Google predictions from 1980. | hodhasharon | |
14/8/2020 15:16 | Sharon, I just told you, going from 50p to 70p...isn't a big swing. You can pick ANY SHARE. If you want a big swinger, check out Farn over the past year. Makes pyc and dddd swings look like chicken feed. | davevt | |
14/8/2020 15:01 | Yes tweets have been giving clues.. interest times ahead. | tonytony4 | |
14/8/2020 14:58 | Yes. I suspect people have seen Physiomics tweets (PLURAL) today and putting 2+2 together. These guys are very conservative If they say 'we can help with covid' that to me translates to 'we have been helping' and there will be public news maybe soon? | the stigologist | |
14/8/2020 14:47 | Is there a buyer in the background! | tonytony4 | |
14/8/2020 14:39 | I now just follow JC. Once this goes below 4p it vomes into JC territory. Ill buy and sell at 11p | spacedust | |
14/8/2020 13:12 | davevt Let it be known that he bottled the challenge to name a single share with profit potential. I rest my case. | hodhasharon | |
14/8/2020 12:27 | Net sales prediction for 2021 up. | myamay16 | |
14/8/2020 11:50 | "davevt14 Aug '20 - 11:47 - 7315 of 7315 So you just admitted your clueless." The irony hehehehehe | hodhasharon | |
14/8/2020 11:38 | I'm here to make money hitman, not to do research, I don't have such skills. ....But what I do have are a very particular set of skills, skills I have acquired over a very long career....skills that make me a nightmare for people like you. | hodhasharon | |
14/8/2020 11:33 | I stopped reading that as soon as "my own" research was mentioned. | thehitman1 | |
14/8/2020 11:29 | A Challenge: Stig suggested I look at DDDD last week. I did my own research, invested, and I'm currently sitting on a healthy profit. Your turn Dave. Give me a stock that you believe has profit in it. I will do my own research, and act accordingly. Time to prove yourself son. | hodhasharon | |
14/8/2020 11:21 | I wouldn't have mentioned Valerx, there are a bag of trouble & a distressed Company. | bobby.ifa | |
14/8/2020 11:19 | 😂😂 'I rely on Stig' The chief ramper that is sitting on the biggest loss than anyone? He's been ramping it longer than anyone, and never made a profit. So why are you following the worst investor this board has ever had? | davevt | |
14/8/2020 11:17 | I don't need to, the price action and volume signatures tell me all I need to know. I rely on the Stig and others for fundamental indicators. | hodhasharon | |
14/8/2020 11:06 | Hod, pyc don't even design drugs. Alongside Stig, in all the years I've been here, you, who have only been here 5 minutes, are the second most clueless one to frequent these boards. Do you actually have any clue what pyc does? | davevt |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions